Historique
Auteur J. BRUNEAU
Documents disponibles écrits par cet auteur (40)
Ajouter le résultat à votre sélection Affiner la recherche
ENGLISH : BACKGROUND: Studies indicate that needle-exchange programmes (NEPs) can reduce the incidence of HIV infection; however, a positive impact of syringe-supply programmes has not been consistently demonstrated. The associations between h[...]
B. NOSYK ; J. E. MIN ; F. HOMAYRA ; M. KURZ ; B. C. GUERRA-ALEJOS ; R. YAN ; M. PISKE ; S. R. SEAMAN ; P. BACH ; S. GREENLAND ; M. E. KARIM ; U. SIEBERT ; J. BRUNEAU ; P. GUSTAFSON ; K. KAMPMAN ; P. T. KORTHUIS ; T. LOUGHIN ; L. C. MCCANDLESS ; R. W. PLATT ; K. T. SCHNEPEL ; M. E. SOCIAS | 2024
Dans Journal of the American Medical Association (Vol.332, n°21, December 3, 2024) Article : PériodiqueKey points: Question: Is buprenorphine/naloxone associated with lower risk of treatment discontinuation and mortality compared with methadone? Findings: In this population-based retrospective cohort study that included 30?891 individuals initi[...]
D. JUTRAS-ASWAD ; G. ZANG ; J. BRUNEAU | 2010
Dans American Journal on Addictions (Vol.19, n°3, May-June 2010) Article : PériodiqueThis study examines whether the relation between acute cannabis use and syringe sharing during single injection days is similar among regular and nonregular users, participating in a cohort study of injection drug users in Montreal, Canada. 236 [...]
P. LAUZON ; J. BRUNEAU ; REMONDIN M. ; S. BRISSETTE ; L. POTVIN ; J. M. BRODEUR | 1996
Dans Psychotropes (Vol.2, n°4, 1996) Article : PériodiqueFRANÇAIS : Plusieurs études ont comparé l'efficacité de la clonidine et de la méthadone dans le traitement du syndrome de retrait des opiacés, sans mettre en évidence des différences importantes entre les deux médicaments sauf pour la présence [...]
R. MOIRAND ; M. BILODEAU ; S. BRISSETTE ; J. BRUNEAU | 2007
Dans Canadian Journal of Gastroenterology (Vol.21, n°6, June 2007) Article : PériodiqueFRANÇAIS : HISTORIQUE ET OBJECTIFS : Afin d'en accroître l'efficacité thérapeutique, la prestation du traitement antiviral contre le virus de l'hépatite C (VHC) devrait augmenter. Pourtant, l'expérience pratique révèle un faible taux de traitem[...]
B. FISHER ; S. BRISSETTE ; S. BROCHU ; J. BRUNEAU ; N. EL-GUEBALY ; L. NOEL ; J. REHM ; M. TYNDALL ; C. WILD ; MUN P. ; E. HAYDON ; D. BALIUNAS | 2004
PériodiqueENGLISH : Background: Drug overdose is a major cause of death and illness among illicit drug users. Previous research has indicated that most illicit drug users experience nonfatal overdoses and has suggested a variety of factors that are asso[...]
J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : PériodiqueThere have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017
Bulletin : Périodique
P. LECLERC ; A. C. VANDAL ; A. FALL ; J. BRUNEAU ; E. ROY ; S. BRISSETTE ; C. P. ARCHIBALD ; N. ARRUDA ; C. MORISSETTE | 2014
Dans Drug and Alcohol Dependence (Vol.142, September 2014) Article : PériodiqueBackground: To plan and implement services to persons who inject drugs (PWID), knowing their number is essential. For the island of Montréal, Canada, the only estimate, of 11,700 PWID, was obtained in 1996 through a capture-recapture method. Thi[...]
ENGLISH : Hepatitis C is an emerging theme of contemporary public health discourses related to illicit drug injection practices. Such discourses differentiate injecting from non-injecting users in an actuarial risk logic, targeting drug-inject[...]![Global patterns of opioid use and dependence: harms to populations, interventions, and future action [Drug use 1]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=82246)
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : PériodiqueWe summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]
J. BRUNEAU ; F. LAMOTHE ; FRANCO E. ; LACHANCE N. ; DESY M. ; SOTO J. ; VINCELETTE J. | 1997
Périodique
ENGLISH : Objectives: To determine whether HIV-exposed, uninfected subjects (EUs) having HIV-specific effector activity are at a reduced risk for seroconverting compared with EUs with no HIV-specific effector responses. Design: Twenty-eight in[...]
E. FORTIER ; S. B. HOJ ; M. P. SYLVESTRE ; A. A. ARTENIE ; N. MINOYAN ; D. JUTRAS-ASWAD ; J. GREBELY ; J. BRUNEAU | 2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : PériodiqueBackground: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may affect HCV infection risk. Thus, this study[...]
